Internal Medicine

Recent research has provided an updated perspective on intensive BP lowering therapy for patients facing high … Is Aggressive BP Control Worth It? HRQoL vs. CV RiskRead more

The management of patients with atrial fibrillation (AF) who have undergone drug-eluting stent (DES) implantation for … Simplified Antithrombotic Therapy for AF Patients Post-StentRead more

Low-Dose Morphine, a treatment often considered for refractory chronic breathlessness, recently failed to show efficacy in … Low-Dose Morphine for Breathlessness: Did a New Trial Fail?Read more

Early pregnancy hemoglobin is a critical predictor of neonatal health, according to a massive new cohort … The U-Shaped Threat: Rethinking Hemoglobin Targets in PregnancyRead more

Patients with Atrial Fibrillation (AF) who underwent coronary stenting more than one year ago need careful … Ditching Clopidogrel? New Data Supports NOAC MonotherapyRead more

The APPAC randomized clinical trial provides the first long-term data exceeding five years on non-operative management … Skip the Knife? 10-Year Data Backs Antibiotics for AppendicitisRead more

Restless Legs Syndrome (RLS) is a pervasive, sleep-related movement disorder significantly impacting approximately 3% of US … Overwhelming Urge to Move: An RLS Clinical Review for DoctorsRead more

Sacituzumab Govitecan, when combined with pembrolizumab, offers a promising new frontline treatment for patients with PD-L1-positive, … New Frontline Hope: Sacituzumab Govitecan + Pembrolizumab for Advanced TNBCRead more

Metabolic bariatric surgery provides better long-term outcomes for Type 2 Diabetes (T2D) than medical and lifestyle … Why Bariatric Surgery Still Tops Medication for Type 2 DiabetesRead more

Long-term Mpox sequelae present a significant challenge for healthcare providers. Before the 2022 multinational clade II … What Doctors Need to Know About Long-Term Mpox SequelaeRead more